UTSW study finds new enzyme with structure that could explain how heart can beat optimally

June 20, 2016

DALLAS - June 20, 2016 - The heart is the only muscle that contracts and relaxes continuously over a lifetime to pump oxygen-rich blood to the body's organs. Researchers at UT Southwestern Medical Center now have identified a previously unrecognized enzyme that could optimize contraction and lead to new strategies to treat heart failure.

The heart's contractions depend on a motor enzyme called myosin pulling on the muscle's fiber-like actin filaments. Those contractions are improved when myosin has a phosphate molecule attached to it (phosphorylation), said Dr. Audrey Chang, Assistant Professor of Physiology and first author of the study, published in today's Proceedings of the National Academy of Sciences.

A constant amount of phosphorylation is essential for normal heart function. The optimum phosphorylation level is maintained by balancing the activities of myosin kinase enzymes that add the phosphate and an opposing enzyme that removes the phosphate. If the amount of phosphorylation is too low, the result is heart failure - which affects about 5.7 million adults in the United States. In addition, animal models with increased myosin phosphorylation have shown enhanced cardiac performance that resists stresses that cause heart failure, explained senior author Dr. James Stull, Professor of Physiology.

The international study led by UT Southwestern identifies a new myosin kinase, called MLCK4, and provides the first three-dimensional structure for any member of the MLCK family, Dr. Stull said.

The researchers found that compared to myosin kinases in other kinds of muscles (skeletal and smooth), the heart-specific MLCK4 lacks a conserved regulatory segment that inhibits kinase activity, a structural finding consistent with biochemical studies that indicated this kinase is always turned on.

In addition, they found that another myosin kinase found only in heart muscle (MLCK3) contains a modified regulatory segment that allows the protein's activity to be enhanced by the calcium modulator protein, calmodulin. Thus, both of the MLCK enzymes that are unique to cardiac muscle provide phosphate to myosin in normal beating hearts to optimize performance and prevent heart failure induced by stresses, Dr. Stull explained.

"The heart-specific expression of these kinases, and the linkage between low myosin phosphorylation and heart failure, makes targeting of these cardiac myosin kinases to improve cardiac function compelling," he said.

Additional studies are underway, Dr. Stull said, to understand the signaling pathways that fine tune kinase activities with the goal of targeting these two kinases therapeutically to improve myosin phosphorylation in those affected by heart failure.
-end-
Dr. Kristine Kamm, Professor of Physiology, was another study author from UT Southwestern. Also contributing were researchers at The University of Oxford, United Kingdom; Goerthe University, Frankfurt, Germany; the Perelman School of Medicine at the University of Pennsylvania; and the University of Florida College of Medicine.

The project was supported by the American Heart Association, the Leducq Foundation, the National Institutes of Health, the Moss Heart Fund, and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology.

About UT Southwestern Medical Center

UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution's faculty includes many distinguished members, including six who have been awarded Nobel Prizes since 1985. The faculty of almost 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide medical care in about 80 specialties to more than 100,000 hospitalized patients and oversee approximately 2.2 million outpatient visits a year.

This news release is available on our home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via email, subscribe at http://www.utsouthwestern.edu/receivenews

UT Southwestern Medical Center

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.